Presenter: Bernard J. Gersh, MB, CH.B, D.PHIL
Professor of Medicine and Chair of Cardiovascular Education
Mayo Clinic Medical School
Bernard J. Gersh, MB, ChB, DPhil, is the Professor of Medicine and Chair of Cardiovascular Education at Mayo Medical School, as well as Consultant of Cardiovascular Diseases and Internal Medicine at the Mayo Clinic in Rochester, Minnesota. He is a co-author of the highly regarded Drugs for the Heart, 8th Edition, as well as the editor of Year Book of Cardiology and a co-editor of Year Book of Medicine.
Dr. Gersh received his medical degree from the University of Cape Town in South Africa, followed by residencies in internal medicine and cardiovascular disease from the Mayo Graduate School of Medicine, and a fellowship in cardiac surgery at National Heart Hospital in London.
Dr. Gersh’s clinical interests are in the natural history and therapy of acute and chronic coronary disease, cardiomyopathies, and clinical electrophysiology, with particular emphasis on atrial fibrillation and syncope. His research involves the Bypass Angioplasty Revascularization Investigation Trial interdigitates with endocrinology; he is involved in the development of a functional genomics program in the field of atrial fibrillation and hypertrophic cardiomyopathy. Dr. Gersh’s additional research focuses on national databases such as the Cooperative Cardiovascular Care/Medicare Database, The National Registry of Myocardial Infarction, and others.
Presenters: David Maron, MD, and William Fearon, MD
Maron: Clinical Professor of Cardiovascular Medicine, Director of Preventive Cardiology
Fearon: Professor of Cardiovascular Medicine, Director of Interventional Cardiology
Stanford University
David Maron, MD
Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014.
William Fearon, MD
Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology and the Society of Cardiovascular Angiography and Interventions. He was elected to the American Society of Clinical Investigation.
Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and is a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He has presented and published a number of abstracts and peer-reviewed papers in this area, and serves on the editorial board of Circulation, the Journal of the American College of Cardiology, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He is the principal investigator on an R01 award from the NIH evaluating cardiac allograft vasculopathy. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement.
Presenter: Mintu Turakhia, MD, MAS
Associate Professor of Cardiovascular Medicine, Stanford University
Mintu Turakhia M.D. M.A.S. is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. Dr. Turakhia has an active, highly-funded multidisciplinary program in atrial fibrillation, where uses large datasets to examine quality, outcomes, and risk prediction for heart rhythm disorders. As the Executive Director of Stanford’s new Center for Digital Health, he is the principal investigator of several multi-center trials to test digital health tools and wearable devices to screen and manage heart rhythm disorders. In his clinical role as Director of Cardiac Electrophysiology at the VA, Dr. Turakhia performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
Presenter: David Morrow, MD
Director, Levine Cardiac Intensive Unit, Professor of Medicine Harvard Medical School
Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS).
He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease.
Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management.
Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors.
Presenter: Eugene Braunwald, MD
Professor of Cardiovascular Medicine, Harvard University
Dr. Eugene Braunwald is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the distinguished Hersey Professor of Medicine at Harvard Medical School (HMS) and faculty dean for academic programs at Partners Healthcare System.
Dr. Braunwald received his medical degree from New York University School of Medicine. He completed an internal medicine residency at The Johns Hopkins Hospital and a cardiology residency at Mount Sinai Hospital. Dr. Braunwald then completed cardiology fellowships at Columbia University College of Physicians and Surgeons and the National Heart Institute. He is board certified in both internal medicine and cardiovascular disease.
Dr. Braunwald is also the founding chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, an academic research organization of BWH and an affiliate of HMS. As chairman of TIMI, Dr. Braunwald and his colleagues have provided significant insight into the treatment of patients who suffer from acute myocardial infarction and unstable angina.
Dr. Braunwald has served as an editor of Harrison’s Principles of Internal Medicine for 12 editions and is the founding editor of Heart Disease, now in its 10th edition, as well as two prominent cardiovascular textbooks. Science Watch listed Dr. Braunwald as the most frequently cited author in cardiology.